OCT 03, 2020 6:00 AM PDT

Test Diagnoses Dementia While You Sleep by Estimating Your Brain Age

WRITTEN BY: Tara Fernandez

Researchers at Harvard have discovered a novel diagnostic marker of dementia for identifying undiagnosed patients or those most at risk of developing the neurodegenerative condition. 

Termed the Brain Age Index, or BAI, the diagnostic model is powered by artificial intelligence and generates a readout based on the difference between a person’s chronological age and their biological brain age. The data used by the algorithm is based on brain activity measurements taken using electroencephalogram, or EEG, while the individual is fast asleep. The higher the BAI, the faster the brain is aging, and the more likely they are to have dementia.

M. Brandon Westover, a senior author of the publication featured in JAMA Network Open said, “The model computes the difference between a person’s chronological age and how old their brain activity during sleep ‘looks,’ to provide an indication of whether a person’s brain is aging faster than is normal.”

The BAI test is a huge leap forward from current tests for estimating a person’s brain age which use expensive magnetic resonance imaging techniques that can not be feasibly taken at regular intervals to track brain activity. Moreover, the BAI can be easily measured at home using simple, cost-effective medical devices like headbands with in-built EEG electrodes.

The researchers validated their BAI platform using over 5,000 sleep tests from individuals diagnosed with dementia, those with mild cognitive impairments, undiagnosed individuals challenged with impairments and over 2,000 healthy volunteers. Clear patterns emerged wherein patients with dementia had, on average, about four years older brain ages than those without.

The researchers see BAI measurements becoming a routine part of primary care with the potential to be a powerful screening and monitoring tool for the presence of neurodegenerative illnesses.


Source: The Harvard Gazette, JAMA Network Open.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
AUG 10, 2020
Cancer
A New Prognostic Biomarker for Paclitaxel Sensitivity in Breast Cancer
AUG 10, 2020
A New Prognostic Biomarker for Paclitaxel Sensitivity in Breast Cancer
Breast cancer is one of the deadliest cancers globally. It has been studied extensively with plenty of treatments availa ...
SEP 24, 2020
Clinical & Molecular DX
2-In-1: Stroke Scans Also Diagnose COVID
SEP 24, 2020
2-In-1: Stroke Scans Also Diagnose COVID
King’s College London researchers took a closer look at emergency room CT scans of patients suspected of having a ...
OCT 14, 2020
Cancer
Using Plasma Scalpels with Chemotherapy Against Brain Cancer
OCT 14, 2020
Using Plasma Scalpels with Chemotherapy Against Brain Cancer
Cold atmospheric plasma is a relatively new technique that utilizes a tool that generates a sort of plasma scalpel, exce ...
OCT 13, 2020
Clinical & Molecular DX
Test for Diabetes Checks If the Liver Is Responding
OCT 13, 2020
Test for Diabetes Checks If the Liver Is Responding
Glucagon is a hormone that prevents blood glucose levels from dropping too low by stimulating the liver to convert store ...
OCT 20, 2020
Clinical & Molecular DX
Non-coding RNA As A Barometer For Liver Health
OCT 20, 2020
Non-coding RNA As A Barometer For Liver Health
October is liver cancer awareness month — a month dedicated to educating people about the risk factors and prevent ...
OCT 23, 2020
Clinical & Molecular DX
Follow Your Heart: A Genetic Predictor of Cardiovascular Disease
OCT 23, 2020
Follow Your Heart: A Genetic Predictor of Cardiovascular Disease
Cardiovascular disease is the leading cause of death globally, resulting in the loss of nearly 18 million lives each yea ...
Loading Comments...